valvular heart disease

Apixaban on Patients With AFib and VHD Had Better Results Than Rivaroxaban, Study Reveals

Apixaban on Patients With AFib, VHD Had Better Results Than Rivaroxaban, Study Reveals

Medicine & Technology Oct 19, 2022

Researchers compared the efficacy and safety of apixaban and rivaroxaban in treating atrial fibrillation and valvular heart disease (VHD). Read the article to know the more on the results of their study.

valvular heart disease

Apixaban on Patients With AFib, VHD Had Better Results Than Rivaroxaban, Study Reveals

Most Popular

How Technology Is Changing the Real Estate Industry?

Nikolay Karpenko Biography, Photo, Career, Accomplishments

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

The Role of AI in the Next Generation of Logistics: Insights from Tobias Waldhecker

China’s Tiangong Space Station to Expand Its Capabilities With New Modules

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission